ETF (BOVX11)

Buy/Sell Ratio
Buy: 30,595,296..........Neutral: 135,000...........Sell: 6,788,497

The Mikah Scam.

Can't expose himself to the big boys on the Nasdaq.

If a company with Elite’s numbers has a stock price in the 0.30s, and they chose to stay on the OTC, then questions have to be asked why .

Nope, the chart doesn't show that, however the chart was super bullish here and I made the most money here than any other ticker, see the results
https://investorshub.advfn.com/uimage/uploads/2021/10/27/xrxxqnsav_378k.PNG

Sold VSCO on the pop.

Grabbed on fri. @26. Washappy....but....darn!

Cyberlux Corporation ($CYBL) has emerged from an 18-month period of malicious, adversarial litigation that has suppressed cash and revenue. With the Texas turnover receiver terminated by court order, the company is now focused fully on business again.

From late 2024 through mid-2026,

CGTL took some got another 180 days extension https://dilution.news/7c54a14976124a9a4c4a1481e39ead6e

https://x.com/suntexcorp/status/2071677508739801276?s=46

34K is the target price after it broke the 80k neckline support of the massive H&S topping pattern, you take the 126k high, minus the 80k neckline equals 46k, then subtract that 46k from the 80k neckline projects to 34k, so simple

CGTL took some got another 180 days extension https://dilution.news/7c54a14976124a9a4c4a1481e39ead6e

Another Russell addition -

Enanta Pharmaceuticals, Inc.(NasdaqGS:ENTA) added to Russell 3000E Growth Benchmark
Published on 06/29/2026 at 12:08 am EDT

https://www.marketscreener.com/news/enanta-pharmaceuticals-inc-nasdaqgs-enta-added-to-russell-3000e-growth-bench

Yep. At rock bottom, cant go wrong here 🚀

Wrong again, ignorance is bliss.

They were issuing press releases for years that never came to fruition. This is when the statute if limitations more than likely would have started. IMHO.

Remember little man, “ should have known”, they would have not reported”. Beca

End of the week 2¢,5¢,10¢...or higher? BOOM!!!

$NICH is quietly hitting every critical milestone:
💰Audit nearing completion: Finalizing a comprehensive two-year audit with a PCAOB-registered firm.
🌐Restoring transparency: Actively working to regain full regulatory reporting status.
✅Disciplined capital all

$NICH is quietly hitting every critical milestone:
💰Audit nearing completion: Finalizing a comprehensive two-year audit with a PCAOB-registered firm.
🌐Restoring transparency: Actively working to regain full regulatory reporting status.
✅Disciplined capital all

I envy guys like you, Kiwi, and others who are connoisseurs and can readily differentiate between various wines. Maybe it is a skill that can be developed through practice. I, unfortunately, like Mark Cuban, couldn't tell the difference between a $5 bottle and a $500 bottle of wine. Now, others t

Quantum Stocks: $QBTS $RGTI $IONQ $QUBT

Stock research in the quantum stock sector, investor conferences.

https://quantummeow.com/newsletter/

Don’t be fooled. He doesn’t own shares.  He just owns shares in a competitor of RDGL. Those bashing own zero shares collectively. An Approval should clean up the board . 

It's amazing isn't it? An investment in a company that has never had a profitable year in over 20 years selling product. Has total liabilities of what they OWE of $18,083,918 with assets of what they OWN of only $142,362. Total sales for the year 2025 of $510,623 with current liabilities due in o

Space x is just fine I brought 152 again up a lot ba k to 200s

Patience

There was a purchase of 198,888 shares at .0075 this morning. 

$AIMN @AimwellPartners enters the $100B+ RegTech market with the launch of AimwellBio. As healthcare becomes the fastest-growing vertical in regulatory tech, Aimwell is building the "trust layer" for AI in medicine.

🔹 Solving the 47% AI error rate in medical advice.
&#x